Clinical Trials
2 trialsNCT00104884 2023-06-28
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT00106431 2019-10-30
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
Celgene
Phase 2 Completed